Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Regenxbio Inc (RGNX)

Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling? Motley Fool - Wed Mar 13, 7:00AM CDT

The threat is still emerging, but it could be significant.

SRPT : 127.39 (+2.53%)
RGNX : 16.06 (+0.12%)
Regenxbio: Q4 Earnings Snapshot AP - Tue Feb 27, 3:32PM CST

Regenxbio: Q4 Earnings Snapshot

RGNX : 16.06 (+0.12%)
Regenxbio: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Regenxbio: Q3 Earnings Snapshot

RGNX : 16.06 (+0.12%)
REGENXBIO to Participate in the Jefferies CNS/Neuro Summit PR Newswire - Thu Oct 5, 2023

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the Jefferies CNS/Neuro Summit on Thursday, October 12, 2023. Jefferies...

RGNX : 16.06 (+0.12%)
REGENXBIO Presents Interim Clinical Data from Phase I/II AFFINITY DUCHENNE™ Trial of RGX-202 at 28th Annual International Congress of the World Muscle Society PR Newswire - Tue Oct 3, 2023

RGX-202, a potential one-time AAV Therapeutic for the treatment of Duchenne that includes an optimized transgene for a novel microdystrophin, continues to be...

RGNX : 16.06 (+0.12%)
REGENXBIO Announces Presentations at the 28th Annual Congress of the World Muscle Society PR Newswire - Tue Sep 26, 2023

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the 28th Annual Congress of the World Muscle Society, taking place in...

RGNX : 16.06 (+0.12%)
REGENXBIO to Participate in Upcoming Investor Conferences PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Morgan Stanley 21st Annual...

RGNX : 16.06 (+0.12%)
Initial Clinical Data of First Pediatric CLN2 Patient Dosed with RGX-181 Presented at SSIEM Annual Symposium PR Newswire - Wed Aug 30, 2023

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that initial interim data from a first-in-human single-patient, investigator-initiated trial of...

RGNX : 16.06 (+0.12%)
REGENXBIO Announces Presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2023 PR Newswire - Wed Aug 23, 2023

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2023...

RGNX : 16.06 (+0.12%)
Regenxbio: Q2 Earnings Snapshot AP - Wed Aug 2, 2023

Regenxbio: Q2 Earnings Snapshot

RGNX : 16.06 (+0.12%)

Barchart Exclusives

This Dividend King Is Now One of BofA's Investment Best Ideas Barchart - Thu Apr 25, 6:30PM CDT
Discover why S&P Global, a seasoned Dividend King, has not only secured a spot on Bank of America's prestigious US 1 List, but also why analysts are bullish about its investment potential in the current economic climate. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot